| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-23507-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35121-10ug | |||
| Carrier-Free | NBP2-35121-1mg | |||
| Carrier-Free | NBP2-35121-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35102-10ug | |||
| Carrier-Free | NBP2-35102-1mg | |||
| Carrier-Free | NBP2-35102-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35024-10ug | |||
| Carrier-Free | NBP2-35024-1mg | |||
| Carrier-Free | NBP2-35024-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12040-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52643-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12084-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2645-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81270SS | |||
![Western Blot: CD47 Antibody (050) [NBP3-23505] - NBP3-23505 at 1:500 dilution. Lane A: Mouse brain tissue Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 35 kDa](http://images.novusbio.com/fullsize/nbp3-23505_rabbit-cd47-mab-050-136202422345027.png "Western Blot: CD47 Antibody (050) [NBP3-23505] - NBP3-23505 at 1:500 dilution. Lane A: Mouse brain tissue Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 35 kDa")
![Immunoprecipitation: CD47 Antibody (050) [NBP3-23505] - CD47 was immunoprecipitated using: Lane A: 0.5 mg Mouse brain Whole Cell Lysate 4 uL NBP3-23505 and 60 ug of Immunomagnetic beads Protein A/G. Primary antibody: NBP3-23505, at 1:100 dilution. Secondary antibody: Goat Anti-Rabbit IgG (H+L) [HRP] at 1/10000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 40 kDa. Observed band size: 40 kDa](http://images.novusbio.com/fullsize/nbp3-23505_rabbit-cd47-mab-050-1362024223411.png)
![Immunohistochemistry-Paraffin: p38 alpha Antibody (0004) [NBP3-23507] - Immunohistochemical analysis of paraffin-embedded human carcinoma of sigmoid tissue,untreated (left) or lambda phosphatase-treated (right), using NBP3-23507 at 1:500 dilution.](http://images.novusbio.com/fullsize/nbp3-23507_rabbit-p38-alpha-mab-0004-235202511444436.png "Immunohistochemistry-Paraffin: p38 alpha Antibody (0004) [NBP3-23507] - Immunohistochemical analysis of paraffin-embedded human carcinoma of sigmoid tissue,untreated (left) or lambda phosphatase-treated (right), using NBP3-23507 at 1:500 dilution.")
![Flow Cytometry: CD3 Antibody (MM1A) [NBP2-60876] - Obtained with bovine leukocytes](http://images.novusbio.com/fullsize/CD3-Antibody-MM1A-Flow-Cytometry-NBP2-60876-img0001.jpg "Flow Cytometry: CD3 Antibody (MM1A) [NBP2-60876] - Obtained with bovine leukocytes")
![SDS-Page: Mouse IL-21 Protein [NBP2-35121]](http://images.novusbio.com/fullsize/Mouse-IL-21-Protein-SDS-Page-NBP2-35121-img0001.jpg "SDS-Page: Mouse IL-21 Protein [NBP2-35121]")
![SDS-Page: Mouse IL-11 Protein [NBP2-35102]](http://images.novusbio.com/fullsize/Mouse-IL-11-Protein-SDS-Page-NBP2-35102-img0001.jpg "SDS-Page: Mouse IL-11 Protein [NBP2-35102]")
![SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]](http://images.novusbio.com/fullsize/Recombinant-Human-IL-13-Variant-Protein-SDS-Page-NBP2-35024-img0002.jpg "SDS-Page: Recombinant Human IL-13 Variant Protein [NBP2-35024]")
![Immunocytochemistry/Immunofluorescence: IL-2 R beta Antibody (5H4) - Chimeric [NBP3-12040] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 5H4 (NBP3-12040) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12040, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/IL-2-R-beta-Antibody-5H4-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12040-img0001.jpg "Immunocytochemistry/Immunofluorescence: IL-2 R beta Antibody (5H4) - Chimeric [NBP3-12040] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 5H4 (NBP3-12040) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12040, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: CD3 epsilon Antibody (500A2) - Chimeric [NBP2-52643] - Mouse lymphocytes were stained with an anti-CD44 control (panel A) or the rabbit-chimeric version of 500A2 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD3-epsilon-Antibody-500A2-Chimeric-Flow-Cytometry-NBP2-52643-img0002.jpg "Flow Cytometry: CD3 epsilon Antibody (500A2) - Chimeric [NBP2-52643] - Mouse lymphocytes were stained with an anti-CD44 control (panel A) or the rabbit-chimeric version of 500A2 (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.](http://images.novusbio.com/fullsize/CCR4-Antibody-KW-0761-Mogamulizumab-Chimeric-Western-Blot-NBP2-81270-img0001.jpg "Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.")